Literature DB >> 17211678

T helper 1 type cytokines polymorphisms: association with susceptibility to Behçet's disease.

Gamze Alayli1, Fatma Aydin, Ahmet Yilmaz Coban, Yüksel Süllü, Ferhan Cantürk, Yüksel Bek, Belma Durupinar, Tayyar Cantürk.   

Abstract

The pathogenesis of Behçet's disease (BD) is not fully understood and immunological abnormalities and genetic factors have been investigated. Because serum concentrations of mainly T helper 1 (Th1) type cells have been reported to be increased in BD, we aimed to investigate whether certain cytokine polymorphisms might represent a risk factor for developing BD. We genotyped 80 patients with BD and 105 healthy controls for interleukin (IL)-1 alpha (T/C -889), IL-1 beta (C/T -511, T/C +3962), IL-1R (C/T pst11970), IL-1RA (T/C mspa111100), IL-2 (T/G -330), IL-12 (C/A -1188), interferon (IFN)-gamma (A/T UTR 5644), and TNF-alpha (G/A -238) polymorphisms. Analyses of cytokine polymorphisms were performed with PCR-SSP. The genotype and allele frequencies of the patients and controls were compared and the association between the polymorphisms of the cytokines with the clinical findings was investigated. Genotype distribution showed significant differences between the patients and the controls for the IL-1 alpha -889, IL-1 beta -511, IL-1 beta +3962, IL-1R, IL-12, IFN- gamma, and TNF-alpha cytokines. We didn't observe significant difference in genotypic frequencies of IL-1RA and IL-2 in our study. Comparison of the IL-1 alpha -889, IL 1 beta -511, and IL 1 beta +3962 genotype frequencies showed significant increase in CC genotype between the patients and the controls. The individuals with IL-1R TT polymorphism had a higher risk for BD compared to patients with CT/CC polymorphism. Comparison of IL-12, IFN- gamma, and TNF-alpha, genotype frequencies showed significant increase in CA, AA, and AA genotypes between the patients and controls, respectively. The frequencies of genotypes according to the clinical features of the patients with BD did not show a significant difference (p>0.05). Our study suggests that development of BD might be determined by various cytokine gene polymorphisms. However, further studies on larger numbers of cases are needed before definite conclusions can be drawn.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17211678     DOI: 10.1007/s10067-006-0503-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  36 in total

1.  IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease.

Authors:  A Nemetz; M P Nosti-Escanilla; T Molnár; A Köpe; A Kovács; J Fehér; Z Tulassay; F Nagy; M A García-González; A S Peña
Journal:  Immunogenetics       Date:  1999-06       Impact factor: 2.846

2.  Interleukin-12p40 genotype plays a role in the susceptibility to multiple sclerosis.

Authors:  T van Veen; J B Crusius; H M Schrijver; G Bouma; J Killestein; L van Winsen; A Salvador Peña; C H Polman; B M Uitdehaag
Journal:  Ann Neurol       Date:  2001-08       Impact factor: 10.422

3.  Behçet's disease: an update on the pathogenesis.

Authors:  A Gül
Journal:  Clin Exp Rheumatol       Date:  2001 Sep-Oct       Impact factor: 4.473

4.  Cytokines in Behçet's disease.

Authors:  N Sayinalp; O I Ozcebe; O Ozdemir; I C Haznedaroğlu; S Dündar; S Kirazli
Journal:  J Rheumatol       Date:  1996-02       Impact factor: 4.666

5.  Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet's disease.

Authors:  J Karasneh; A H Hajeer; J Barrett; W E R Ollier; M Thornhill; A Gul
Journal:  Rheumatology (Oxford)       Date:  2003-04-16       Impact factor: 7.580

6.  TNF and TNF receptor polymorphisms in Korean Behcet's disease patients.

Authors:  Eun Bong Lee; Jeong Yeon Kim; Yun Jong Lee; Myoung Hee Park; Yeong Wook Song
Journal:  Hum Immunol       Date:  2003-06       Impact factor: 2.850

7.  Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States.

Authors:  C G Parks; G S Cooper; M A Dooley; E L Treadwell; E W St Clair; G S Gilkeson; J P Pandey
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

8.  Interleukin-1 genotype and outcome of unrelated donor bone marrow transplantation.

Authors:  Margaret L MacMillan; Gretchen A Radloff; Todd E DeFor; Daniel J Weisdorf; Stella M Davies
Journal:  Br J Haematol       Date:  2003-05       Impact factor: 6.998

9.  Role of IL-12B promoter polymorphism in Adamantiades-Behcet's disease susceptibility: An involvement of Th1 immunoreactivity against Streptococcus Sanguinis antigen.

Authors:  Hirokatsu Yanagihori; Noritaka Oyama; Koichiro Nakamura; Nobuhisa Mizuki; Keiji Oguma; Fumio Kaneko
Journal:  J Invest Dermatol       Date:  2006-03-02       Impact factor: 8.551

10.  Mapping the HLA association in Behçet's disease: a role for tumor necrosis factor polymorphisms?

Authors:  Tariq Ahmad; Graham R Wallace; Teifi James; Matt Neville; Mike Bunce; Kim Mulcahy-Hawes; Alessandro Armuzzi; Jonathan Crawshaw; Farida Fortune; Robert Walton; Miles R Stanford; Ken I Welsh; Sara E Marshall; Derek P Jewell
Journal:  Arthritis Rheum       Date:  2003-03
View more
  15 in total

1.  The role of IL-23/IL-17 axis in the etiopathogenesis of Behçet's disease.

Authors:  Rui-Xue Leng; Gui-Mei Chen; Hai-Feng Pan; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2010-07-13       Impact factor: 2.980

Review 2.  Association of cytokine gene polymorphisms (IL‑6, IL‑12B, IL‑18) with Behcet's disease : A meta-analysis.

Authors:  Y Xu; K Zhou; Z Yang; F Li; Z Wang; F Xu; C He
Journal:  Z Rheumatol       Date:  2016-11       Impact factor: 1.372

3.  Serum IL-33 level and IL-33 gene polymorphisms in Behçet's disease.

Authors:  Suleyman Serdar Koca; Murat Kara; Firat Deniz; Metin Ozgen; Caner Feyzi Demir; Nevin Ilhan; Ahmet Isik
Journal:  Rheumatol Int       Date:  2014-08-14       Impact factor: 2.631

Review 4.  Associations between interleukin-1 polymorphisms and susceptibility to vasculitis: a meta-analysis.

Authors:  G G Song; J-H Kim; Y H Lee
Journal:  Z Rheumatol       Date:  2016-05       Impact factor: 1.372

5.  Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients.

Authors:  Cemile Sonmez; Aysegul Atak Yucel; Turan Hilmi Yesil; Hamit Kucuk; Berna Sezgin; Ridvan Mercan; Ahmet Eftal Yucel; Gulderen Yanikkaya Demirel
Journal:  Clin Rheumatol       Date:  2018-03-20       Impact factor: 2.980

6.  Interleukin-1 gene cluster and IL-1 receptor polymorphisms in Iranian patients with systemic lupus erythematosus.

Authors:  Zahra Tahmasebi; Mahmoud Akbarian; Sedigheh Mirkazemi; Abtin Shahlaee; Zahra Alizadeh; Ali Akbar Amirzargar; Ahmad Reza Jamshidi; Shima Ghoroghi; Shiva Poursani; Keramat Nourijelyani; Mahdi Mahmoudi
Journal:  Rheumatol Int       Date:  2013-05-31       Impact factor: 2.631

7.  Expression of Th-17 and RORγt mRNA in Behçet's Disease.

Authors:  Kamel Hamzaoui; Eya Bouali; Imed Ghorbel; Monia Khanfir; Habib Houman; Agnes Hamzaoui
Journal:  Med Sci Monit       Date:  2011-04

8.  mRNA Expression Level of Interleukin Genes in the Determining Phases of Behçet's Disease.

Authors:  Serpil Taheri; Murat Borlu; Cem Evereklioglu; Sevda Yesim Ozdemir; Yusuf Ozkul
Journal:  Ann Dermatol       Date:  2015-05-29       Impact factor: 1.444

9.  Genetic variations of IL-12B, IL-12Rβ1, IL-12Rβ2 in Behcet's disease and VKH syndrome.

Authors:  Xinyu Li; Lin Bai; Jing Fang; Shengping Hou; Qingyun Zhou; Hongsong Yu; Aize Kijlstra; Peizeng Yang
Journal:  PLoS One       Date:  2014-05-23       Impact factor: 3.240

10.  Polymorphisms in the tumor necrosis factor gene and susceptibility to Behcet's disease: an updated meta-analysis.

Authors:  Min Zhang; Wang-Dong Xu; Peng-Fei Wen; Yan Liang; Jie Liu; Hai-Feng Pan; Dong-Qing Ye
Journal:  Mol Vis       Date:  2013-09-12       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.